Kurs & Likviditet
|2023-05-17||Extra Bolagsstämma 2023|
|2022-11-24||Ordinarie utdelning SELECT B 0.00 SEK|
|2021-11-25||Ordinarie utdelning SELECT B 0.00 SEK|
|2020-11-26||Ordinarie utdelning SELECT B 0.00 SEK|
|2019-11-21||Ordinarie utdelning SELECT B 0.00 SEK|
|Industri||Läkemedel & Handel|
On November 23, 2022, SelectImmune Pharma AB (publ) hekd its annual general meeting. A summary of the decisions made are listed below. All decisions were made unanimously.
Determining the income statement and balance sheet as well as distribution of income
The meeting decided to determine the income statement and balance sheet as included in
the presented annual report. The meeting decided to dispose of the company's results
according to the board's proposal in the annual report. Furthermore, it was decided that no
dividend will be paid for the financial year 2021/2022.
Discharge from liability
It was decided to grant the members of the board and the former and current managing
director freedom from liability for the period covered by the annual report presented at the
meeting. The members of the board or the managing director did not participate in this
Determining the number of board members, board deputies and the number of auditors
as well as determining the fees for the board and the auditors
The meeting decided that the board shall consist of five members without deputies and that
an auditor shall be appointed without deputies. The meeting further decided that directors
remuneration shall amount to a total of no more than SEK 225,000, with the following
distribution: The chairman and CEO shall not receive remuneration, while members who are
not employees of the company shall each receive SEK 75,000. It was decided that the fee to
the auditor should be paid according to an approved bill.
Election of board and auditor
It was decided to appoint Catharina Svanborg, Gabriela Godaly, Carl-Johan Wachtmeister,
Helena Lomberg and Magnus Nylén (new member) as board members for the time until the
end of the next annual general meeting. It was also decided to appoint Catharina Svanborg
as chairman of the board. Furthermore, it was decided to appoint the registered auditing
company Revisorsgruppen i Malmö AB as auditor until the next annual general meeting.
Revisorsgruppen in Malmö AB has announced that they will appoint the auditor Per Ranstam
as chief auditor.
SelectImmune Pharma AB 559104-6874
THE BOARD OF DIRECTORS